The impact of chronic stress on alcohol and drug abuse among middle-aged adults of different races
Chronic Stressors and Alcohol and Drug Abuse in Middle-aged Adults: White/BlackDifferences
This study is looking at how ongoing stress affects drinking and drug use in middle-aged adults, especially comparing white and Black communities, to find ways to help improve health for those dealing with these challenges.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10893617 on NIH RePORTER |
What this research studies
This research investigates how chronic stressors affect alcohol and drug abuse among middle-aged adults, focusing on differences between white and Black populations. It aims to understand the relationship between individual and community stressors and their impact on health outcomes over time. The study will involve a nationwide survey to collect data on psychosocial factors, social engagement, and access to health services, which may influence substance use behaviors. By analyzing these factors, the research seeks to identify potential interventions to improve health outcomes for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are middle-aged adults, particularly those experiencing chronic stress and issues related to alcohol and drug use.
Not a fit: Patients who are not middle-aged or do not struggle with substance abuse or chronic stress may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted interventions that reduce alcohol and drug abuse among middle-aged adults, improving overall health and well-being.
How similar studies have performed: Previous research has shown that addressing psychosocial factors can significantly impact substance abuse outcomes, suggesting that this approach may be effective.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Rospenda, Kathleen M — University of Illinois at Chicago
- Study coordinator: Rospenda, Kathleen M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.